{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:40:01Z","timestamp":1783485601455,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T00:00:00Z","timestamp":1521849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Giulini SpA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s13555-018-0233-6","type":"journal-article","created":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T13:19:25Z","timestamp":1521897565000},"page":"259-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Drug Treatment for Androgenetic Alopecia: First Italian Questionnaire Survey on What Dermatologists Think about Finasteride"],"prefix":"10.1007","volume":"8","author":[{"given":"Elisabetta","family":"Sorbellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Marzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,24]]},"reference":[{"issue":"Suppl 1","key":"233_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-4362.1999.00002.x","volume":"38","author":"A Tosti","year":"1999","unstructured":"Tosti A, Piraccini BM. Androgenetic alopecia. Int J Dermatol. 1999;38(Suppl 1):1\u20137.","journal-title":"Int J Dermatol"},{"key":"233_CR2","unstructured":"Paus R, Olsen EA, Messenger AG. Hair growth disorders. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, et al., editors. Fitzpatrick\u2019s dermatology in general medicine. 7th ed. New York: McGraw-Hill; 2007. p. 753\u201377."},{"issue":"5","key":"233_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4103\/0378-6323.116730","volume":"79","author":"F Kaliyadan","year":"2013","unstructured":"Kaliyadan F, Nambiar A, Vijayaraghavan S. Androgenetic alopecia: an update. Indian J Dermatol Venereol Leprol. 2013;79(5):613\u201325 (review).","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"233_CR4","first-page":"15","volume":"149","author":"BM Piraccini","year":"2014","unstructured":"Piraccini BM, Alessandrini A. Androgenetic alopecia. G Ital Dermatol Venereol. 2014;149(1):15\u201324 (review).","journal-title":"G Ital Dermatol Venereol"},{"issue":"2","key":"233_CR5","doi-asserted-by":"publisher","first-page":"e1006594","DOI":"10.1371\/journal.pgen.1006594","volume":"13","author":"SP Hagenaars","year":"2017","unstructured":"Hagenaars SP, Hill WD, Harris SE, et al. Genetic prediction of male pattern baldness. Noethen MM, ed. PLoS Genet. 2017;13(2):e1006594.","journal-title":"PLoS Genet"},{"issue":"3","key":"233_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1749-6632.1951.tb31971.x","volume":"53","author":"JB Hamilton","year":"1951","unstructured":"Hamilton JB. Patterned loss of hair in man; types and incidence. Ann NY Acad Sci. 1951;53(3):708\u201328.","journal-title":"Ann NY Acad Sci"},{"issue":"6","key":"233_CR7","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1111\/j.1365-2133.2003.05565.x","volume":"149","author":"G Severi","year":"2003","unstructured":"Severi G, Sinclair R, Hopper JL, English DR, McCredie MR, Boyle P, Giles GG. Androgenetic alopecia in men aged 40\u201369\u00a0years: prevalence and risk factors. Br J Dermatol. 2003;149(6):1207\u201313.","journal-title":"Br J Dermatol"},{"issue":"3","key":"233_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1087-0024.2005.10102.x","volume":"10","author":"DC Gan","year":"2005","unstructured":"Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc. 2005;10(3):184\u20139.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"2","key":"233_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2133.2009.09186.x","volume":"161","author":"L Yip","year":"2009","unstructured":"Yip L, Zaloumis S, Irwin D, Severi G, Hopper J, Giles G, Harrap S, Sinclair R, Ellis J. Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss. Br J Dermatol. 2009;161(2):289\u201394.","journal-title":"Br J Dermatol"},{"issue":"2","key":"233_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ecl.2007.03.004","volume":"36","author":"N Otberg","year":"2007","unstructured":"Otberg N, Finner AM, Shapiro J. Androgenetic alopecia. Endocrinol Metab Clin North Am. 2007;36(2):379\u201398.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"233_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/0738-081X(88)90074-0","volume":"6","author":"AM Kligman","year":"1988","unstructured":"Kligman AM. The comparative histopathology of male pattern baldness and senescent baldness. Clin Dermatol. 1988;6:108\u201318.","journal-title":"Clin Dermatol"},{"key":"233_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1087-0024.2005.10125.x","volume":"10","author":"R Hoffmann","year":"2005","unstructured":"Hoffmann R, Van Neste D. Recent findings with computerized methods for scalp hair growth measurements. J Invest Dermatol Symp Proc. 2005;10:285\u20138.","journal-title":"J Invest Dermatol Symp Proc"},{"key":"233_CR13","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.4065\/80.10.1316","volume":"80","author":"D Stough","year":"2005","unstructured":"Stough D, Stenn K, Haber R, Parsley WM, Vogel JE, Whiting DA, et al. Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clin Proc. 2005;80:1316\u201322.","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 6","key":"233_CR14","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1610-0379.2011.07802.x","volume":"9","author":"A Blumeyer","year":"2011","unstructured":"Blumeyer A, Tosti A, Messenger A, Reygagne P, et al. European Dermatology Forum (EDF). Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges. 2011;9(Suppl 6):S1\u201357.","journal-title":"J Dtsch Dermatol Ges"},{"key":"233_CR15","first-page":"A316","volume":"38","author":"E Olsen","year":"1997","unstructured":"Olsen E. Finasteride (1\u00a0mg) in the treatment of androgenetic alopecia in men. Aust J Dermatol. 1997;38:A316 (abstract).","journal-title":"Aust J Dermatol"},{"key":"233_CR16","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/archdermatol.2010.256","volume":"146","author":"JM Mella","year":"2010","unstructured":"Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol. 2010;146:1141\u201350.","journal-title":"Arch Dermatol"},{"issue":"14","key":"233_CR17","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s40265-016-0629-5","volume":"76","author":"Y Kelly","year":"2016","unstructured":"Kelly Y, Blanco A, Tosti A. Androgenetic alopecia: an update of treatment options. Drugs. 2016;76(14):1349\u201364.","journal-title":"Drugs"},{"key":"233_CR18","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S0190-9622(98)70007-6","volume":"39","author":"KD Kaufman","year":"1998","unstructured":"Kaufman KD, Olsean EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39:578\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"233_CR19","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1046\/j.1365-4362.1999.00804.x","volume":"38","author":"S Brenner","year":"1999","unstructured":"Brenner S, Matz H. Improvement in androgenic alopecia in 53\u201376\u00a0years old men using oral Finasteride. Int J Dermatol. 1999;38:928\u201330.","journal-title":"Int J Dermatol"},{"issue":"4","key":"233_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1529-8019.2011.01441.x","volume":"24","author":"A Rossi","year":"2011","unstructured":"Rossi A, Cantisani C, Scarn\u00f2 M, Trucchia A, Fortuna MC, Calvieri S. Finasteride, 1\u00a0mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up. Dermatol Ther. 2011;24(4):455\u201361.","journal-title":"Dermatol Ther"},{"key":"233_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/sj.ijir.3901017","volume":"15","author":"DJ Carbone Jr","year":"2003","unstructured":"Carbone DJ Jr, Hodges S. Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life. Int J Impot Res. 2003;15:299\u2013306.","journal-title":"Int J Impot Res"},{"key":"233_CR22","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1111\/j.1743-6109.2007.00563.x","volume":"4","author":"N Mondaini","year":"2007","unstructured":"Mondaini N, Gontero P, Giubilei G, et al. Finasteride 5\u00a0mg and sexual side effects: how many of these are related to a nocebo phenomenon? J Sex Med. 2007;4:1708\u201312.","journal-title":"J Sex Med"},{"key":"233_CR23","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S0190-9622(99)70081-2","volume":"40","author":"J Leyden","year":"1999","unstructured":"Leyden J, Dunlap F, Miller B, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermaol. 1999;40:930\u20137.","journal-title":"J Am Acad Dermaol"},{"key":"233_CR24","first-page":"38","volume":"12","author":"KD Kaufman","year":"2002","unstructured":"Kaufman KD. Long-term (5-year) multinational experience with finasteride 1\u00a0mg in the treatment of men with androgenetic alopecia. Eur J Dermatol. 2002;12:38\u201349.","journal-title":"Eur J Dermatol"},{"key":"233_CR25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/jnci\/djm023","volume":"99","author":"CM Moinpour","year":"2007","unstructured":"Moinpour CM, Darke AK, Donaldson GW, et al. Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2007;99:1025\u201335.","journal-title":"J Natl Cancer Inst"},{"key":"233_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1046\/j.1468-3083.2001.00315.x","volume":"15","author":"A Tosti","year":"2001","unstructured":"Tosti A, Piraccini BM, Soli M. Evaluation of sexual function in subjects taking finasteride for the treatment of androgenic alopecia. J Eur Acad Dermatol Venereol. 2001;15:418\u201321.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"233_CR27","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.jsxm.2016.07.006","volume":"13","author":"L Liu","year":"2016","unstructured":"Liu L, Zhao S, Li F, Li E, Kang R, Luo L, Luo J, Wan S, Zhao Z. Effect of 5\u03b1-reductase inhibitors on sexual function: a meta-analysis and systematic review of randomized controlled trials. J Sex Med. 2016;13(9):1297\u2013310.","journal-title":"J Sex Med"},{"issue":"2","key":"233_CR28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/CND.0b013e3181873cca","volume":"10","author":"TM Al-Harbi","year":"2008","unstructured":"Al-Harbi TM, Kagan J, Tarnopolsky MA. Finasteride-induced myalgia and hyperCKemia. J Clin Neuromuscul Dis. 2008;10(2):76\u20138.","journal-title":"J Clin Neuromuscul Dis"},{"issue":"2","key":"233_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/andr.12147","volume":"4","author":"G Chiriac\u00f2","year":"2016","unstructured":"Chiriac\u00f2 G, Cauci S, Mazzon G, Trombetta C. An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia. Andrology. 2016;4(2):245\u201350.","journal-title":"Andrology"},{"key":"233_CR30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.22543\/2392-7674.1039","volume":"3","author":"S Paunica","year":"2016","unstructured":"Paunica S, Giurgiu M, Vasilache A, et al. Finasteride adverse effects and post-finasteride syndrome; implications for dentists. J Mind Med Sci. 2016;3:71\u20139.","journal-title":"J Mind Med Sci"},{"issue":"2","key":"233_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1346-8138.2011.01361.x","volume":"39","author":"R Tsuboi","year":"2012","unstructured":"Tsuboi R, Itami S, Inui S, et al. Guidelines planning committee for the management of androgenetic alopecia. Guidelines for the management of androgenetic alopecia. J Dermatol. 2012;39(2):113\u201320.","journal-title":"J Dermatol"},{"key":"233_CR32","first-page":"155798831775098","volume":"1","author":"AA Walf","year":"2018","unstructured":"Walf AA, Kaurejo S, Frye CA. Research brief: self-reports of a constellation of persistent antiandrogenic, estrogenic, physical, and psychological effects of finasteride usage among men. Am J Mens Health. 2018;1:1557988317750989.","journal-title":"Am J Mens Health"},{"key":"233_CR33","first-page":"864","volume-title":"IADVL textbook of dermatology","author":"SL Wadhwa","year":"2008","unstructured":"Wadhwa SL, Khopkar U, Nischal KC. Hair and scalp disorders. In: Valia RG, Valia AR, editors. IADVL textbook of dermatology. 3rd ed. Mumbai: Bhalani; 2008. p. 864\u2013948.","edition":"3"},{"issue":"1","key":"233_CR34","first-page":"38","volume":"12","author":"The Finasteride Male Pattern Hair Loss Study Group","year":"2002","unstructured":"The Finasteride Male Pattern Hair Loss Study Group. Long-term (5-year) multinational experience with finasteride 1\u00a0mg in the treatment of men with androgenetic alopecia. Eur J Dermatol. 2002;12(1):38\u201349.","journal-title":"Eur J Dermatol"},{"key":"233_CR35","doi-asserted-by":"crossref","unstructured":"Patton T, Korman NJ. Oral systemic agents for immunobullous disorders. In: Yamauchi P, editor. Biologic and systemic agents in dermatology. Cham: Springer; 2018.","DOI":"10.1007\/978-3-319-66884-0_35"},{"issue":"1","key":"233_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1046\/j.1523-1747.2003.12167.x","volume":"8","author":"J Shapiro","year":"2003","unstructured":"Shapiro J, Kaufman KD. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). J Investig Dermatol Symp Proc. 2003;8(1):20\u20133.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"4","key":"233_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2164\/jandrol.108.006007","volume":"30","author":"AM Traish","year":"2009","unstructured":"Traish AM. Androgens play a pivotal role in maintaining penile tissue architecture and erection: a review. J Androl. 2009;30(4):363\u20139.","journal-title":"J Androl"},{"issue":"5","key":"233_CR38","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1111\/j.1743-6109.2012.02661.x","volume":"9","author":"MG Zhang","year":"2012","unstructured":"Zhang MG, Wu W, Zhang CM, Wang XJ, Gao PJ, Lu YL, Shen ZJ. Effects of oral finasteride on erectile function in a rat model. J Sex Med. 2012;9(5):1328\u201336.","journal-title":"J Sex Med"},{"issue":"1","key":"233_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.eururo.2013.08.048","volume":"65","author":"AM Isidori","year":"2014","unstructured":"Isidori AM, Buvat J, Corona G, Goldstein I, Jannini EA, Lenzi A, Porst H, Salonia A, Traish AM, Maggi M. A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. Eur Urol. 2014;65(1):99\u2013112.","journal-title":"Eur Urol"},{"key":"233_CR40","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S0190-9622(99)70081-2","volume":"40","author":"J Leyden","year":"1999","unstructured":"Leyden J, Dunlap F, Miller B, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermaol. 1999;40:930\u20137.","journal-title":"J Am Acad Dermaol"},{"issue":"6","key":"233_CR41","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/j.1743-6109.2011.02255.x","volume":"8","author":"MS Irwig","year":"2011","unstructured":"Irwig MS, Kolukula S. Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med. 2011;8(6):1747\u201353.","journal-title":"J Sex Med"},{"issue":"3","key":"233_CR42","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/j.1743-6109.2010.02157.x","volume":"8","author":"AM Traish","year":"2011","unstructured":"Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML. Adverse side effects of 5\u03b1-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients. J Sex Med. 2011;8(3):872\u201384.","journal-title":"J Sex Med"},{"key":"233_CR43","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.ajpath.2012.03.044","volume":"181","author":"F Marra La","year":"2012","unstructured":"La Marra F, Di Loreto C, Mazzon G. Preliminary evidence of a peculiar hormonal profile in men with adverse effects after use of finasteride against androgenetic alopecia. Am J Pathol. 2012;181:S8.","journal-title":"Am J Pathol"},{"issue":"4","key":"233_CR44","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.5301\/jbm.5000095","volume":"29","author":"E Cecchin","year":"2014","unstructured":"Cecchin E, De Mattia E, Mazzon G, Cauci S, Trombetta C, Toffoli G. A pharmacogenetic survey of androgen receptor (CAG)n and (GGN)n polymorphisms in patients experiencing long term side effects after finasteride discontinuation. Int J Biol Markers. 2014;29(4):e310\u20136.","journal-title":"Int J Biol Markers"},{"issue":"6","key":"233_CR45","doi-asserted-by":"publisher","first-page":"e100237","DOI":"10.1371\/journal.pone.0100237","volume":"9","author":"C Loreto Di","year":"2014","unstructured":"Di Loreto C, La Marra F, Mazzon G, Belgrano E, Trombetta C, Cauci S. Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia. PLoS ONE. 2014;9(6):e100237.","journal-title":"PLoS ONE"},{"issue":"3","key":"233_CR46","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/1557988314538445","volume":"9","author":"CA Ganzer","year":"2015","unstructured":"Ganzer CA, Jacobs AR, Iqbal F. Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms. Am J Mens Health. 2015;9(3):222\u20138.","journal-title":"Am J Mens Health"},{"issue":"7","key":"233_CR47","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/phar.1612","volume":"35","author":"AK Ali","year":"2015","unstructured":"Ali AK, Heran BS, Etminan M. Persistent sexual dysfunction and suicidal ideation in young men treated with low-dose finasteride: a pharmacovigilance study. Pharmacotherapy. 2015;35(7):687\u201395.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"233_CR48","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/MED.0000000000000158","volume":"22","author":"MS Irwig","year":"2015","unstructured":"Irwig MS. Safety concerns regarding 5\u03b1-reductase inhibitors for the treatment of androgenetic alopecia. Curr Opin Endocrinol Diabetes Obes. 2015;22(3):248\u201353.","journal-title":"Curr Opin Endocrinol Diabetes Obes"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-018-0233-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13555-018-0233-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-018-0233-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:42:38Z","timestamp":1751499758000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13555-018-0233-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,24]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["233"],"URL":"https:\/\/doi.org\/10.1007\/s13555-018-0233-6","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,24]]},"assertion":[{"value":"5 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}